Individuals born with low birth weight (LBW) are at risk of developing type 2 diabetes mellitus (T2D), which may be precipitated by physical inactivity. Twenty-two LBW subjects and twenty-three controls were studied before and after bed rest by the hyperinsulinemic euglycemic clamp combined with indirect calorimetry and infusion of stable isotope tracers and preceded by an intravenous glucose tolerance test. LBW subjects had a similar body mass index but elevated abdominal obesity compared with controls. The basal rate of whole body lipolysis (WBL) was elevated in LBW subjects with and without correction for abdominal obesity before and after bed rest (all P ϭ 0.01). Skeletal muscle hormone-sensitive lipase (HSL) protein expression and phosphorylation at Ser565 were similar in the two groups. Bed rest resulted in a decrease in WBL and an increased skeletal muscle HSL Ser565 phosphorylation indicating a decreased HSL activity in both groups. All subjects developed peripheral insulin resistance in response to bed rest (all P Ͻ 0.0001) with no differences between groups. LBW subjects developed hepatic insulin resistance in response to bed rest. In conclusion, increased WBL may contribute to the development of hepatic insulin resistance when exposed to bed rest in LBW subjects. Nine days of bed rest causes severe peripheral insulin resistance and reduced WBL and skeletal muscle HSL activity, as well as a compensatory increased insulin secretion, with no differences in LBW subjects and controls. physical inactivity; insulin resistance; prediabetic subjects PHYSICAL ACTIVITY IS AN IMPORTANT environmental moderator of metabolism, and sedentary lifestyle has been identified as a major risk factor for the metabolic syndrome, including type 2 diabetes mellitus (T2D), hypertension, and dyslipidemia (7, 9, 12, 18, 41) . Thus there is an urgent need to gain more insight into the impact of physical inactivity on physiological mechanisms involved in the development of T2D and metabolic syndrome (23) (24) (25) . Previous studies (28, 29) of physical inactivity in healthy individuals showed that 7 days bed rest diminished whole body glucose uptake as a result of decreased insulin action in inactive muscles. The Dallas Bed Rest and Training Study showed that 3 wk of bed rest caused a decrease in maximal exercise capacity (V O 2 max ) comparable to 30 yr of aging (26, 27 ).
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An association between low birth weight (LBW) and impairment of glucose homeostasis was first proposed by Hales and Barker in 1991 (17) . Since then, several studies have confirmed and elaborated on these findings, thereby highlighting the importance of the intrauterine environment in the development of diseases in adulthood, including hypertension, cardiovascular disease (16) , and abnormal glucose tolerance (35, 37, 43) . Accordingly, studies from the UK (2) as well as from our group (19, 20, 30, 31, 34 -36, 39) have provided evidence in favor of an important additional role of an adverse intrauterine environment associated with LBW in the development of insulin resistance, obesity, and T2D. The previous discovery of lower birth weight in monozygotic twins with T2D compared with their genetically identical nondiabetic co-twins ruled out the possibility that the association between T2D and LBW could simply be due to a coincidence between the putative T2D susceptibility genotype and a genetically determined LBW (35) . Subsequent studies by our group have documented several prediabetic characteristics and defects of metabolism in young subjects with LBW, including abdominal obesity (36, 44) , mildly elevated plasma glucose concentrations (20) , resistance of insulin to enhance whole body glycolysis (20) and forearm muscle glucose uptake (19) , abnormal muscle fiber type composition (21) , reduced expression of a range of key insulin-signaling proteins in fat and skeletal muscles (30, 31) , decreased insulin secretion in response to oral glucose ingestion (20) , as well as evidence of homeostasis model assessment (HOMA) and hepatic insulin resistance (10, 44) . We found previously that LBW subjects had lower fasting plasma glycerol levels, suggesting a reduced whole body lipolysis (WBL) rate, and speculated that this may be associated with an increased risk of developing abdominal obesity. However, other studies have shown an increased rate of adipocyte lipolysis in response to catecholamine infusions using the microdialysis technique as well as an increased rate of lipolysis in isolated adipocytes in LBW subjects (8, 40) . We are unaware of any studies of glycerol turnover rates or WBL in healthy or prediabetic subjects when exposed to physical inactivity.
In this study, we hypothesized that healthy, but potentially prediabetic, young men born with LBW are more sensitive to the detrimental effects of physical inactivity on insulin action and secretion, as well as on glucose and fat metabolism, including lipolysis, compared with healthy controls of normal birth weight. Furthermore, we speculated that physical inac-tivity may unmask underlying additional metabolic defects associated with LBW, enabling us to gain deeper insight into the molecular mechanisms linking LBW with the increased risk of developing insulin resistance and T2D.
SUBJECTS AND METHODS
The data presented in this study are part of a larger study on the influence of physical inactivity in healthy and prediabetic subjects. This work was initiated and is funded by the European Union Framework VI EXGENESIS project.
Subjects
Forty-five healthy males were recruited via the Danish National Birth Registry according to birth weight. Twenty-two had LBW [birth weight Յ 10
th percentile] and twenty three were matched controls with normal birth weight (50 th percentile Յ birth weight Յ 75 th percentile). All men were singletons, born at term in Copenhagen. The two groups were matched according to age, body mass index, and physical fitness. All potential subjects were screened over the phone. Subjects with a body mass index Ͼ 30 kg/m 2 and V O2 max Ͼ 55 ml O 2 · min Ϫ1 ·kg Ϫ1 were excluded to avoid studying metabolic changes due to high body weight or a high level of physical activity. Subjects who had another disease known to affect study outcomes and those who were alcohol or drug abusers were also excluded. All the subjects were screened with a fasting plasma glucose measurement, and two subjects with newly diagnosed diabetes (2 LBWs) were excluded.
Furthermore, two subjects from the LBW group and three from the control group declined their consent after the prebed rest period (3 subjects had problems with compliance and 2 others could not cope with the intensity of the intervention program) and were not studied after bed rest.
Ethical Approval
The study was approved by the Copenhagen and Frederiksberg Regional Ethics Committee (Ref. No. 01-262546). All procedures were performed in accordance with the guidelines of the Declaration of Helsinki. Informed written consent was obtained from all subjects before participation.
Experimental Protocol
Control period. Subjects were requested to abstain from strenuous physical activity and from consuming alcohol 3 days before examination. To ensure standardized conditions, all subjects were provided an isocaloric nutritionally standardized diet 3 days before the day of the first clamp study and during bed rest with adjusted caloric content to ensure weight stability. Body composition, fat-free mass, and fat mass were determined by dual-energy X-ray absorptiometry scan (Lunar Prodigy Advance, GE Healthcare). Maximal aerobic capacity (V O2 max) was measured on a bicycle ergometer with a stepwise incremental test using the leveling-off criterion (Jaeger Instruments, Höchberg, Germany).
Bed rest challenge studies. All subjects were admitted to Steno Diabetes Center for 9 days and were not permitted to deviate from a half-recumbent position during this period. Toilet visits, limited to total of 15 min per day, were allowed. Study subjects were allowed to use a laptop computer, watch television, and read in bed. Blood samples for measurements of fasting plasma insulin and C-peptide were taken in the morning of the first, second, third, fifth, seventh, and ninth day of bed rest. All subjects were provided a standardized isocaloric nutritionally recommended diet consisting of 55 energy percent (E%) of carbohydrates, 15 E% of protein, and 30 of E% fat 3 days before the control studies as well as during the entire 9 days of bed rest experiments with adjusted caloric contents to ensure weight stability. Body weight of all subjects was recorded every morning throughout the intervention to ensure weight stability.
Hyperinsulinemic euglycemic clamp(s) combined with stable isotope infusion and indirect calorimetry. Identical in vivo experiments
were performed before and after the bed rest intervention studies. A schematic presentation of the experimental day(s) is presented in Fig. 1 Blood samples for measurements of fatty acid (FA), glycosylated hemoglobin (HbA 1C), total cholesterol (C), HDL-C, LDL-C, VLDL-C, and triglycerides were drawn at baseline, and blood samples for measurement of FA in the insulin-stimulated state were drawn at 360 min.
To determine ␤-cell function, an intravenous glucose-tolerance tests (IVGTT) was initiated after the basal period. A glucose bolus of 0.3 g/kg body wt was infused over 1 min. Plasma samples for glucose, insulin, and C-peptide were collected at 150, 152, 154, 156, 158, 160, 165, 170, and 180 min. Following the IVGTT, a primed-continuous insulin infusion was initiated and fixed at 80 mU · m Ϫ2 · min Ϫ1 through the 180-min clamp (180 -360 min). A variable infusion of unlabeled or cold glucose (180 g/l) was used to maintain euglycemia during insulin infusion. Plasma glucose concentration was monitored every 5 min during the clamp and in the second steady state using a blood glucose meter (OneTouch; LifeScan, Milpitas, CA). The target blood glucose concentration was 5 mmol/l, and the infusion rate was adjusted as necessary immediately following each plasma glucose assessment. Samples for measurements of plasma insulin and Cpeptide in the IVGTT period were drawn at 0, 120, 240, 270, 300, 330, and 360 min. Urine samples were collected at 0 and 360 min.
The indirect calorimetry technique is based on measurements of gaseous exchange in vivo, and the method gives a net estimate of whole body glucose oxidation from endogenous and exogenous sources. Oxygen consumption (V O2) and carbon dioxide production (V CO2) were measured during steady state using indirect calorimetry with a computerized flow-through canopy gas-analyzer system (Deltatrac; Datex, Helsinki, Finland) as previously described (13) .
Biochemical and tracer analyses. Blood samples for plasma insulin, C-peptide, FA, triglyceride, and blood samples for glucose and glycerol enrichment determination were centrifuged immediately at 4°C, and plasma samples were stored at Ϫ80°C. Plasma insulin and C-peptide concentrations were determined by AutoDELPHIA timeresolved fluoroimmunoassay (Perkin Elmer-Wallac Oy; Turku, Finland). FA was quantified by an enzymatic colorimetric method (Wako, Richmond, VA). Glycosylated hemoglobin (HbA1C) was measured by high-performance liquid chromatography on a Bio-Rad Variant TM (Bio-Rad Laboratories, Hercules, CA). Plasma triglyceride concentration was determined with triglyceride GPO-PAP (Roche Diagnostic, Mannheim, Germany). Total-C and HDL-C were assessed with an enzymatic colorimetric test (Roche Diagnostic, Mannheim, Germany). LDL-C was calculated from the Friedewald formula (22), and VLDL-C was calculated as plasma triglyceride divided by 2.2. Plasma was enzymatically examined for glycerol and lactate (FA-C kit; Wako Chemical, Neuss, Germany) on an automatic analyzer (Cobas Fara, Roche, Switzerland).
Glucose enrichment was measured as previously described in detail (33) . Briefly, 20 l plasma were shaken with 100 l ethyl acetate to remove lipids. After centrifugation (15,000 rpm for 5 min), the ethyl acetate was discarded and 20 l 8 mol NaOH, 1 mol K 2HPO4, and 10 l benzoylchloride were added, and the solution was vortexed for 5 min. The solution was then neutralized by adding 10 l H3PO4, and the glucose derivate, hexobenzoyl glucose, was extracted by briefly shaking with 500 l ethyl acetate. The ethyl acetate phase was separated by centrifugation and transferred to a new Eppendorf tube, and the ethyl acetate was evaporated under a stream of nitrogen. The glucose derivate was dissolved in a high-performance buffer. The solution was filtered before being analyzed using a liquid chromatography-mass spectrometry system (aQa; Finnigan, Manchester, UK).
Glycerol enrichment was measured by gas chromatography-mass spectrometry (GC-MS, Automass II; Finnigan). In preparing for the GC-MS analysis, plasma samples were processed to make a trifluorobutyrate derivative of glycerol. For the preparation of the fluorobutyrate derivative of glycerol, 3 ml ethanol:chloroform (2.3:1) were added to 200 l plasma, and the solution was mixed and centrifuged. The top layer was extracted once more with 2 ml chloroform and 1 ml water (pH 2, with HCl), mixed, and centrifuged. The top layer was then evaporated under a stream of nitrogen. Two hundred microliters of heptafluorobutyric acid anhydride in ethyl acetate (1:3 v/v) were added to the residue and heated for 10 min at 70°C. The solution was evaporated under a stream of nitrogen, and the residue was redissolved in 1 ml ethyl acetate.
Glycerol enrichment was determined by splitless injection of a 1-l volume into a capillary fused-silica column (CP-SIL 8CB; Chrompack, Middelburg, Netherlands). The isotopic enrichment of glycerol was determined using electron-impact ionization, selectively monitoring ions at a mass-to-charge ratio (m/z) of 252-256, which represents the molecular ions of unlabeled (252) and labeled derivatives (256), respectively. The actual plasma glycerol enrichment was determined using a glycerol-enrichment calibration curve.
Muscle lysate preparation. Freeze-dried and dissected muscle tissue was homogenized in an ice-cold buffer (1:80 wt:vol) containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 20 mM Na pyrophosphate, 20 mM ␤-glycerophosphate, 10 mM Na fluoride, 2 mM Na orthovanadate, 2 mM EDTA, 1 mM EGTA, 1% Nonidet P-40, 10% glycerol, 2 mM PMSF, 10 g/ml leupetin, 10 g/ml aprotinin, and 3 mM benzamidine using a tissue lyser (TissueLyser II; Retsch, Haan, Germany). Lysates was prepared as previously described (1) and stored at Ϫ80°C until analysis. The lysate protein content was assessed using the bicinchoninic acid method (Pierce, Rockford, IL).
Western blotting. The protein expression of hormone sensitive lipase (HSL) and HSL-Ser565 phosphorylation was determined by SDS-PAGE and Western blotting on the muscle lysates. Primary antibodies were rabbit anti-HSL (kindly donated by Dr. Cecilia Holm, Dept. of Cell And Molecular Biology, University of Lund, Sweden) and sheep anti-phospho-HSL Ser565 (kindly donated by Dr. G. Hardie, Division of Molecular Physiology, University of Dundee, Dundee, UK). Secondary antibodies were horseradish peroxididaseconjugated anti-rabbit and anti-sheep (cat. no.81-1620; Zymed, Carlsbad, CA). Antigen-antibody complexes were visualized using enhanced chemiluminescence (Immobilion Western; Millipore, Billerica, MA) and quantified using a Kodak Image station 2000MM (Kodak, Glostrup, Denmark).
No contamination by adipocytes surrounding the muscle fibers was found in the samples (data not shown). This was measured by Western blotting against perilipin as previously described (1) .
Calculations IVGTT (␤-cell test).
The area under the curve (AUC) was calculated using a trapezoidal method for glucose and insulin during the first phase insulin response (FPIR; 0 -10 min) of the IVGTT. PHI 1 (phi 1) was calculated as [AUCinsulin(0-10 min)/AUCglucose(0 -10 min)] and the incremental FPIR during the IVGTT as [AUCinsulin(0-10 min) Ϫ AUCbasal(ins 0 * 10 min)]. The insulin secretion disposition index expressing the inverse hyperbolic relationship between insulin secretion and insulin action may represent a better estimate of the "true" in vivo pancreatic ␤-cell insulin secretion capacity. The "peripheral" insulin secretion disposition index (D i-peripheral.) was calculated as (FPIR * M). Furthermore, we calculated the "hepatic" insulin secretion disposition index (Di-hepatic) as (FPIR/HIR). The hepatic insulin resistance index was calculated as the product of mean fasting plasma insulin concentration and basal hepatic glucose production (3).
Hyperinsulinemic euglycemic clamp and indirect calorimetry. Glucose infusion rates were calculated as the mean of steady-state glucose infusion rates during the predefined insulin-stimulated steady-state period from 150 to 180 min. Basal and insulin stimulated glucose and lipid oxidation were calculated according to Frayn (14) .
Glucose oxidation ϭ 4.55 ϫ V CO2 (l/min) Ϫ 3.21 ϫ V O2 (l/min) Ϫ 2.87 ϫ n; fat oxidation ϭ 1.67 ϫ V CO2 (l/min ) Ϫ 1.67 ϫ V O2 (l/min) Ϫ 1.92 ϫ n; protein oxidation ϭ 6.25 ϫ n; where n equals grams of urinary nitrogen per minute and V O2 and V CO2 are obtained by indirect calorimetry.
Stable isotope tracer calculations. Tracer-to-tracee ratios (TTRs) for glucose and glycerol were calculated as the ratio between the master peak (M) and the enriched peak (M ϩ 2) and (M ϩ 4), respectively, after subtracting the background enrichments. The calculations are based on the assumption of steady state.
For glucose the total rate of appearance, R a(endogenous) was calculated as follows:
where R a(endogenous) is a rate of appearance (mol·kg FFM Ϫ1 ·min
), Ftotal is the total infusion rate of glucose tracer (mol·kg FFM Ϫ1 ·min
Ϫ1
), Eglucose is the enrichment of glucose in plasma expressed as the TTR, and Ra of glucose is a measure of endogenous glucose production and represents hepatic glucose production in basal state (45) .
For glycerol, the total rate of appearance, R a(endogenous) was calculated as follows:
where R a(endogenous) is the rate of appearance (mol·kg FFM Ϫ1 ·min
), Rd is a rate of disappearance (mol·kg FFM Ϫ1 ·min
), Ftotal is the total infusion rate of glycerol tracer (mol·kg FFM Ϫ1 ·min
) corrected with glycerol correction factor (0.7), Eglycerol is the enrichment of glucose in plasma expressed as a TTR, and Ra of glycerol is a measure of WBL in the basal state.
This method is based on several assumptions, including that glycerol cannot be reused within the adipocytes, that it is not produced metabolically by any other pathway (e.g., glycolysis) other than WBL, and that gut output of glycerol is apparently small (45) .
Statistics. Statistical analysis was performed with the SAS Statistical Analysis Package (version 9.1; SAS Institute, Cary, NC). Multiple linear regression analyses were carried out to test for differences between the LBW and controls before and after bed rest. The paired t-test was used to detect statistically significant differences within groups in response to bed rest. The Kolmogorov-Smirnov test was used to check normality of distributions. Data that significantly deviated from the normal distribution were logarithmically transformed. P values Ͻ0.05 were considered significant. Data are presented as means Ϯ SD.
RESULTS

Clinical Characteristics of Study Participants
On average, at birth LBW subjects were ϳ1.3 kg lighter than those of the control group (P Ͻ 0.0001) and were shorter (P Ͻ 0.001) and lighter at the time of the study (P ϭ 0.01). The fat-free mass measured by the dual-energy X-ray absorptiometry scan was significantly lower in the LBW group (P ϭ 0.01) before and after bed rest ( Table 1) . As presented in Table 1 , LBW subjects had a significantly higher trunk-fat mass (FM)-to-total FM ratio, a lower leg FM-to-total FM ratio and a higher percentage trunk FM-to-leg FM ratio before as well as after the intervention. Plasma HDL-C concentration was significantly decreased in both groups in response to bed rest ( Table 1) .
Impact of Bed Rest on Insulin Secretion, Insulin Action, and Gaseous Exchange
A decrease in whole body insulin sensitivity was seen in all subjects in response to bed rest as indicated by the HOMA insulin resistance index (all P Ͻ 0.05) and supported by data from the hyperinsulinemic euglycemic clamp (all P Ͻ 0.0001; Fig. 2 ). Basal plasma insulin concentrations were significantly higher in LBW and control subjects (both P Ͻ 0.05) in response to bed rest (Table 2 ). However, we found significantly higher levels of fasting plasma insulin and C-peptide (all P Ͻ 0.05) in LBW subjects on the first day of on-ward experimental bed rest exposure (Fig. 3, A and B) . Furthermore, we found that the incremental first phase insulin resistance, PHI1 (corrected for glucose AUC) and PHI1 adjusted for M value at baseline increased significantly in response to bed rest in both study groups (Table 3) . D i-peripheral insulin secretion, expressed in relation to the degree of peripheral insulin action, was similar before and after intervention in the two groups. When insulin secretion was calculated with respect to the degree of hepatic insulin action (D i-hepatic ), we also found similar values in response to bed rest in both groups (Table 2) . In other words, insulin secretion proportionally increased after bed rest when seen in relation to peripheral and hepatic insulin action.
No differences in FA, lactate, or glycerol concentration in plasma in the basal or insulin-stimulated states were found Data are means Ϯ SD. BR, bed rest. FFM, fat-free mass; BMI, body mass index; V O2max, maximal oxygen consumption; BP, blood pressure. W/H ratio, weight-to-height ratio; FM, fatty mass; C, cholesterol. *P Ͻ 0.05, significant difference between LBW and control group before bed rest; †P Ͻ 0.05, significant difference between LBW and control group after bed rest; ‡P Ͻ 0.05, significant difference before vs. after bed rest; §log-transformed data. between the groups. We observed a significant decrease in plasma concentrations of FA and glycerol in the basal state in response to bed rest, as well as a significant decrease in insulin-stimulated p-lactate in response to bed rest in both groups (Table 2) .
Basal glucose oxidation increased significantly and basal fat oxidation decreased significantly in response to bed rest in both groups. However, the insulin-stimulated glucose and fat oxidation rates were not significantly affected by bed rest. Both LBW and controls experienced significant decreases in insulinstimulated nonoxidative glucose metabolism in response to bed rest (all P Ͻ 0.01; Table 2 ).
Impact of Bed Rest on Stable Isotope Tracer Kinetics
As presented in Table 4 , the LBW group had a significantly higher rate of WBL before and after bed rest (both P Ͻ 0.05; Fig. 4) . The increased WBL rate in the LBW subjects remained significant even after correction for abdominal obesity (i.e., the ratio between trunk and total fat mass) before and after bed rest (both P ϭ 0.01). The rate of WBL tended to decrease in response to bed rest in both groups. When the two groups were combined, the average decrease of WBL (from 3.6 Ϯ 2.3 to 2.8 Ϯ 1.5 mol·kg FFM Ϫ1 ·min Ϫ1 ) was statistically significant (P Ͻ 0.05).
LBW, but not controls, exhibited an increase in hepatic insulin resistance index (P Ͻ 0.05) in response to bed rest (Fig. 5 and Table 4 ). There were no statistically significant differences in basal R a of glucose between the groups, either before or after bed rest.
HSL Expression and Phosphorylation
No differences in muscle HSL protein content or Ser565 phosphorylation were observed before or after the intervention between the groups (Fig. 6) . In response to bed rest, a decrease in HSL protein expression and Ser565 phosphorylation was found only in controls. When related to total HSL protein, there was a significant increased HSL-Ser565 phosphorylation after bed rest in both LBW and control subjects (Fig. 6 ).
DISCUSSION
In this study, we showed that the basal rate of WBL, but not of plasma FA concentration, was significantly elevated in young, healthy men born with LBW before and after 9 days of bed rest. Both LBW subjects and controls developed peripheral insulin resistance and a compensatory elevation of insulin secretion with no differences between groups when exposed to bed rest. Interestingly, LBW subjects, but not controls, developed hepatic insulin resistance in response to bed rest. The data indicate that an increased rate of WBL independent of abdominal obesity represents a primary defect of metabolism in LBW subjects, contributing 
Data are means Ϯ SD. IS, insulin stimulation; HOMA-IR, homeostasis model assessment-insulin resistance; Di-peripheral, peripheral disposition index, a measure for peripheral insulin action; Di-hepatic, measure for hepatic insulin action. *P Ͻ 0.05, significant difference before vs. after bed rest; †log-transformed data.
to the development of hepatic insulin resistance, and perhaps later T2D, when exposed to a Western lifestyle including physical inactivity.
An increased rate of WBL and the elevation of plasma fatty acids are a hallmark of T2D and have long been thought to play a key role in the development of insulin resistance in T2D patients. Indeed, an increased WBL rate may exhibit detrimental effects on hepatic and peripheral insulin action via the Randle cycle (11) and perhaps via even more widespread effects of fatty acids on metabolism (38) . Our finding of increased WBL in LBW subjects is consistent with previous reports of increased lipolysis in isolated adipocytes (40) as well as in microdialysates from adipose tissue in LBW subjects when exposed to catecholamine challenges (8) . Our data add to those of previous reports documenting increased WBL present even in the nonchallenged fasting state. Interestingly, the increased rate of WBL in LBW subjects persisted after correcting for their greater abdominal obesity. Moreover, we noted that the rate of WBL is increased in young, nonobese men with LBW even before significant impairment of insulin secretion or peripheral insulin action are detectable, and most interestingly, even before plasma FA or glycerol levels are elevated. This may be explained by a compensatory increased clearance rate and/or elevated reesterification of FA and glycerol in these young, nonobese LBW subjects, which in turn may also explain our previous finding of reduced fasting plasma glycerol levels in LBW subjects (21) . Thus our (20) previous interpretation that slightly lower fasting plasma glycerol levels in LBW subjects were caused by a reduced rate of WBL may not be correct. FA is cleared by several mechanisms, including reesterification in adipose tissue, and we speculate that one key mechanism responsible for increased glycerol clearance in LBW subjects could operate at the site of hepatic gluconeogenesis, where it contributes to an elevated rate of hepatic glucose production during certain metabolic states in LBW subjects (10) . Indeed, we observed a significant increase in the hepatic insulin resistance index in response to bed rest in the LBW group, and we hypothesize that a disproportionately increased rate of endogenous glucose production in response to bed rest may well represent an adverse mechanism contributing to the development of abnormal glucose tolerance, and eventually T2D, in LBW subjects with time (Fig.  5) . Furthermore, we speculate that the balanced increased plasma FA and glycerol clearance, and subsequently normal plasma FA and glycerol levels, in the young and lean LBW subjects in this study may explain the normal in vivo insulin secretion and peripheral insulin action before and after bed rest in LBW subjects. However, if or when LBW subjects become obese, the scenario may change, and the elevated WBL may cause significant elevations of plasma FA levels; redistribution of fat from subcutaneous tissue to muscle, pancreas, and liver; and possibly impairments of insulin secretion and action as a consequence of lipotoxicity. Although this remains to be demonstrated in obese LBW subjects as well as in prospective studies, our data indicate that the elevation of WBL may represent a central and primary defect of metabolism that predisposes LBW subjects to developing overt insulin resistance and T2D.
Although bed rest generally decreased WBL, significantly higher WBL was seen in LBW subjects before and after bed rest, indicating the consistency and potentially significant impact on metabolism during various different states of Fig. 3 . A: plasma insulin during 9 days of bed rest (*P Ͻ 0.05). Data are means Ϯ SE for LBW () and control (CON; OE) subjects. B: plasma C-peptide during 9 days of bed rest (*P Ͻ 0.05). Data are means Ϯ SE for LBW () and control (OE) subjects. physical activity in LBW subjects. Moreover, we found a significant decrease in plasma FA and plasma glycerol levels, as well as in the fat oxidation rate in the basal state, in response to 9 days of bed rest in both groups of subjects ( Table 2 ). These changes most likely occurred as a result of the documented decreased rate of WBL with no compensatory elevated FA or glycerol clearance during bed rest in the combined study group. We are unaware of any studies reporting a decreased rate of WBL in response to bed rest in humans, a relationship that may contribute to an increased risk of obesity when individuals are exposed to physical inactivity. Notably, this demonstrates that elevated plasma FA concentrations per se do not explain or contribute to insulin resistance during physical inactivity in young healthy men with normal weight or LBW. Increased WBL is known to occur during transition from rest to moderate exercise, and Wolfe et al. (46) argued that this was a consequence of the combination of the increased appearance of plasma FA from WBL and the reduced rate of reesterification of plasma FA. Van Hall et al. (42) investigated skeletal muscle FA and glycerol kinetics during rest, exercise, and recovery and concluded that whole body FA reesterification is unchanged during transition from rest to exercise. However, FA reesterification increased during recovery and skeletal muscle glycerol uptake increased manyfold during exercise (42) .
In the present study, HSL protein expression and phosphorylation were measured in skeletal muscle as a marker of muscle lipolysis. No differences were obtained in either total HSL protein content or HSL phosphorylation on Ser565 between LBW and control subjects before bed rest (Fig. 6) . Hence, basal lipolysis in skeletal muscle did not contribute to the higher basal WBL rate obtained in LBW compared with controls. On the other hand, in response to bed rest, a significant increased HSL-Ser565 phosphorylation per total HSL protein was found in both LBW and control groups, suggesting a decreased HSL activation (15) . Thus a novel finding of the present study is that skeletal muscle HSL activity decreased with bed rest, suggesting that in addition to adipose tissue the lipolytic rate also drops in skeletal muscle tissue after 9 days of bed rest.
The discovery of HOMA insulin resistance in LBW subjects at day 1 of the bed rest challenges is in accordance with previous studies (20) , and the lack of significant differences in fasting plasma insulin and glucose values before bed rest may be due to chance or that fewer subjects were studied here than in previous studies (10, 44) . In particular, the differences in fasting measurements before bed rest compared with the initial measurements during on-ward bed rest experiments suggest that lifestyle factors, including diet and, in particular, physical activity, were more controlled in the latter case. However, after the first day and during the entire course of the bed rest experiments, fasting plasma insulin and HOMA insulin resistance measurements increased in both study groups, converging toward a similar degree of insulin resistance after exposure to the intervention.
Although skeletal muscle tissue is generally considered to be the tissue primarily responsible for in vivo insulin action in healthy and insulin-resistant individuals (32, 41) , caution is warranted concerning young men with LBW subjects. Thus we previously showed reduced insulin-stimulated forearm (muscle) glucose uptake in LBW subjects with apparently normal b P Ͻ 0.05, significant difference between LBW and control subjects before bed rest; c P Ͻ 0.05, significant difference between LBW and control subjects after bed rest; d P Ͻ 0.05, significant difference between LBW and control subjects before bed rest after adjustment for abdominal obesity by linear regression model;
f P Ͻ 0.05, significant difference between LBW and control subjects after bed rest after adjustment for abdominal obesity by linear regression model. whole body insulin action and glucose uptake rate (20) , and we cannot rule out the possibility that muscle glucose clearance may be decreased in the LBW subjects compared with controls during bed rest. Nevertheless, the present data demonstrate that reduced insulin-stimulated muscle glucose uptake does not precondition LBW subjects to develop a more severe degree of whole body peripheral insulin resistance when exposed to physical inactivity. As seen previously in healthy subjects (28, 29) , the impairment of peripheral insulin action was accounted for solely by an impairment of nonoxidative glucose metabolism, presumably reflecting muscle glycogen synthesis. Previous studies demonstrated that insulin secretion compensates for the degree of muscle insulin resistance (4, 5, 5) and that insulin secretion and insulin action are inversely related (6) . That is why we need to correct insulin secretion for the ambient degree of in vivo muscle insulin action and calculate the disposition index (D i ) to obtain a true measurement of in vivo ␤-cell function (6) . However, there is no agreement about the extent to which hepatic or peripheral insulin action should be used in the calculation of the D i . We calculated the insulin D i in two ways, including either hepatic or muscle insulin action (Table  2) . When including peripheral insulin action, the D i-peripheral was unaltered by bed rest, demonstrating appropriate compensation of the ␤-cell in the prediabetic LBW group as well as controls. Thus the experimental data did not support our a priori hypothesis that young men with LBW at increased risk of developing T2D were unable to compensate for insulin resistance with a disproportionately lower increase of insulin secretion induced by bed rest. The relative energy contribution of carbohydrate, fat, and protein was the same during the two experiments, and we therefore do not believe that differences in macronutrient intake per se between control and bed rest experiments have influenced the results.
In conclusion, his study provides further confirmation of an abnormal metabolic phenotype including an increased rate of WBL that is independent of the degree of abdominal obesity in healthy young men with LBW. Nine days of bed rest causes severe peripheral insulin resistance, reduced WBL and skeletal muscle HSL activity, as well as a compensatory increased insulin secretion, with no differences in LBW subjects and controls. Increased WBL may contribute to the development of hepatic insulin resistance, and potentially to T2D, in LBW subjects when exposed to physical inactivity, perhaps even more so if LBW subjects become obese.
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